Oncimmune Holdings (LSE:ONC) EV-to-FCF : -3.10 (As of Jun. 04, 2024)

Oncimmune Holdings EV-to-FCF Chart

Oncimmune Holdings Annual Data
	Trend	May14	May15	May16	May17	May18	May19	May20	May21	May22	Aug23
EV-to-FCF		Get a 7-Day Free Trial					-7.04	-8.12	-25.89	-11.30	-2.83

Oncimmune Holdings Semi-Annual Data
	May14	Nov14	May15	Nov15	May16	Nov16	May17	Nov17	May18	Nov18	May19	Nov19	May20	Nov20	May21	Nov21	May22	Feb23	Aug23	Feb24
EV-to-FCF	Get a 7-Day Free Trial															-	-11.30	-	-2.83	-

Competitive Comparison of Oncimmune Holdings's EV-to-FCF

For the Biotechnology subindustry, Oncimmune Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncimmune Holdings's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncimmune Holdings's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Oncimmune Holdings's EV-to-FCF falls into.

Oncimmune Holdings EV-to-FCF Calculation

Oncimmune Holdings's EV-to-FCF for today is calculated as:

Oncimmune Holdings's current Enterprise Value is £19.03 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Oncimmune Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Feb. 2024 was £-6.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncimmune Holdings  (LSE:ONC) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Oncimmune Holdings's PE Ratio for today is calculated as:

Oncimmune Holdings's share price for today is £0.1785.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Oncimmune Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 was £0.110.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Oncimmune Holdings EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Oncimmune Holdings's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncimmune Holdings (LSE:ONC) Business Description